Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
To guide our collaborative, globe-spanning alliance, GA4GH relies on a Standards Steering Committee and an Executive Committee.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across four Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Solve your real-world data problems with support from this valuable network of global institutions.
Work with like-minded groups committed to better data use in areas like rare disease, cancer, and infectious disease.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
30 Sep 2021
Robert Freimuth and Alex Wagner, leaders within the GA4GH Genomic Knowledge Standards (GKS) Work Stream, have each received a Genomic Innovator Award from the National Human Genome Research Institute (NHGRI).
Two NHGRI Genomic Innovator Awards support coordinated development of genomic knowledge standards
Two leaders within the GA4GH Genomic Knowledge Standards (GKS) Work Stream have each been awarded a Genomic Innovator Award from the National Human Genome Research Institute (NHGRI) in recognition of their contributions to impactful consortia-based team science.
Robert Freimuth, an Associate Professor of Biomedical Informatics at Mayo Clinic, and Alex Wagner, an Assistant Professor at Nationwide Children’s Hospital and the Ohio State University, each received a 5-year, early-stage investigator award that provides flexible funding to support their ongoing research into the most pressing and rapidly-evolving challenges facing genomic science. Their awards will help them drive the coordinated development of GA4GH standards for the exchange of knowledge between genomic knowledgebases, electronic health records, and other clinical systems.
Wagner’s award will support his efforts to build a generalized genomic knowledge framework that can represent the complex relationships between genomic variant knowledge and evidence across multiple domains. Freimuth will use his award to develop technologies, built in part on GA4GH products, that will enable more seamless integration of genomic data within both research and clinical settings.
As a member of the Mayo Clinic’s Center for Individualized Medicine (CIM), Freimuth leads the development of systems to enable the integration of genomic test results into the Electronic Health Record (EHR) and the delivery of genomic-based recommendations to the point of care through EHR-integrated clinical decision support and apps. His research program focuses on developing scalable infrastructure that facilitates the use of genomic data for clinical practice.
Wagner’s research program focuses on the standardized representation of genomic knowledge. His expertise in this area stems from his role in creating the Clinical Interpretations of Variants in Cancer (CIViC) knowledgebase, and later the harmonization of that content with other knowledgebases through the Variant Interpretation for Cancer Consortium (VICC), a GA4GH Driver Project.
“Unfortunately, many of the genomics standards in use today were developed primarily to meet either research or clinical use cases, and it can be difficult to use different standards together,” said Freimuth, who co-leads the GKS Work Stream. “For instance, there is a significant gap in our ability to capture clinical genomic interpretations as standardized, structured data that are linked to computationally unambiguous representations of genomic variation.”
Wagner, who serves on the GA4GH Steering Committee as Director of VICC, concurred: “There are major gaps in the field resulting from heuristics the community has agreed upon to cover the most common cases. But standardized computational representation of molecular variation is critically important to scaling genomic medicine.”
Both researchers—who first met through GA4GH, and have become close collaborators and friends—see the work of the GKS Work Stream as an important foundation for filling those gaps. The current focus of GKS lies in the evaluation and definitions of forward-looking formats and implementations for representation and annotation of genomic variants.
Wagner co-leads the development of the flagship GKS standard, the Variation Representation Specification (VRS; pronounced “verse”), which provides a flexible framework of computational models, schemas, and algorithms to precisely and consistently exchange genetic variation data across communities. He also leads the development of an emerging framework called VRSATILE (pronounced “versatile” — VRS Added Tools for Interoperable Loquacious Exchange), which aims to advance standards for representing genomic knowledge while keeping a pragmatic view of how knowledge is stored and exchanged today.
For his part, Freimuth sees the award as an opportunity to drive interoperability across disparate standards organizations, such as Health Level 7 (HL7). Freimuth co-chairs the HL7 Clinical Genomics Working Group, which develops Fast Healthcare Interoperability Resources (FHIR) specifications for clinical genomic tests. The Genomic Innovator Award will support his work on the integration of GA4GH and HL7 standards. “GKS is developing technologies that will fill gaps in clinical standards like FHIR, ultimately improving our ability to use genomic data for patient care,” said Freimuth.
“Incorporating GA4GH products into FHIR and other standards for clinical data exchange is a metric of our success,” said Wagner. “Our awards support complementary activities for the development and application of a genomic knowledge framework that can interface between EHR and clinical variant knowledgebases.”